Navigation Links
Vasogen Announces 2007 Year-End Results
Date:1/16/2008

MISSISSAUGA, ON, Jan. 16 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), today reported the results of operations for the fiscal year ended November 30, 2007. All dollar amounts referenced herein are in Canadian dollars unless otherwise noted.

At November 30, 2007, our cash and cash equivalents totaled $23.5 million, compared with $30.4 million at November 30, 2006. The change in our cash position resulted mainly from cash used for operations partially offset by cash provided by financing activities. Our net cash used for operations for the three months ended November 30, 2007, was $4.5 million.

The net loss for the fourth quarter of 2007 was $6.1 million, or $0.27 per common share. We incurred a net loss for the year ended November 30, 2007 of $28.8 million, or $1.46 per common share, compared with a net loss of $66.4 million, or $7.05 per common share for the same period in 2006. The key drivers of our reduced losses in 2007 are lower research and development expenses as a result of the completion of our phase III clinical programs in 2006, the corporate costs associated with supporting these programs, and a reduction in expenses associated with our senior convertible notes. These reductions in expenses were partially offset by restructuring costs. The difference between cash used in operations and our accounting loss is driven by non-cash items, such as expenses related to our senior convertible notes and stock options, as well as unrealized foreign exchange gains and losses.

Highlights

- The results from the phase III ACCLAIM trial of our Celacade(TM)

System in patients with chronic heart failure were accepted for

publication in The Lancet, a world-leading medical
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Tabletop SEMs are inexpensive ... but have limited performance and capability such as small ... SEMs would normally provide better imaging performance and more ... and have a higher cost of maintenance. The ... between these two types of SEM product, offering competitive ...
(Date:6/18/2013)... 18, 2013 (PRWEB) June 18, 2013 ... attendance system in North America, has introduced AccountLinx ... data and payroll records between ExakTime’s software and ... automates ExakTime software setup and keeps employee databases ... data from a business’ current payroll software, directly ...
(Date:6/18/2013)... DuPont welcomes 48 of the nation’s ... National AgriScience Teachers Ambassador Academy this week (NATAA) at ... , The NATAA “Ag Academy” is a ... special project of the National FFA Foundation ... . The highly recommended agriscience teachers, who are ...
(Date:6/18/2013)... 18, 2013  regulated information — Global biopharmaceutical company ... today announced the launch of a new Pledge campaign ... The Pledge empowers the millions of ... make a personal commitment to demand more: greater understanding ... team and additional partial-onset seizure control.  More information is ...
Breaking Biology Technology:Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3ExakTime Introduces AccountLinx Plus 2DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... Pioneering Contributions to Personalized Medicine Cited for Honor ... Ruano, M.D., Ph.D., was inducted into the American ... of Fellows today at a ceremony in Washington, ... of this honor are chosen for exceptional leadership ...
... Insurance Coverage of Hepatitis C Patients Is Skewed ... Private Coverage in the General Population, According to ... Feb. 12 Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that hepatitis C ...
... RICHMOND, Va., Feb. 12 Insmed Inc.,(Nasdaq: ... on niche markets with unmet medical needs, announced today ... & Co., Inc. whereby Merck,through an affiliate, will purchase ... the terms of the agreement, Insmed will receive a,total ...
Cached Biology Technology:American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows 2Hepatitis C Virus Patient Opportunity Exists Within Many of the Major U.S. Local Markets 2Hepatitis C Virus Patient Opportunity Exists Within Many of the Major U.S. Local Markets 3Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 2Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 3Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 4
(Date:6/18/2013)... very large "dead zone" in the Gulf of Mexico ... Chesapeake Bay this year, based on several NOAA-supported forecast ... Louisiana State University, and the Louisiana Universities Marine ... hypoxic "dead" zone will be between 7,286 and 8,561 ... largest recorded. That would range from an area the ...
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
(Date:6/18/2013)... Association for Molecular Pathology is proud to announce it ... Biology (FASEB) on July 1, 2013. The FASEB Board ... , The 26 constituent societies of FASEB represent ... for the advancement of research and education in biological ... more important now than ever," said Jennifer L. Hunt, ...
Breaking Biology News(10 mins):NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... Knowing how a living cell works means knowing ... functions of the cell change. Protein phosphorylation, for example, ... to signaling, and even programmed cell death (apoptosis), in ... that has long been intensively studied, not least in ...
... vitamin, but a new research report appearing in the ... is more than that. According to the report, insufficient levels ... innate immune defenses that protect us from infections, neoplasias or ... winter when days are shorter and sunlight is relatively weak, ...
... HAMILTON, ON, April 30, 2012 Urban beach closures ... yet water-testing technology has never been fast enough to keep ... waters. , Now, researchers at McMaster University have developed a ... detect E. coli in recreational water within minutes. ...
Cached Biology News:Molecular spectroscopy tracks living mammalian cells in real time as they differentiate 2Molecular spectroscopy tracks living mammalian cells in real time as they differentiate 3Molecular spectroscopy tracks living mammalian cells in real time as they differentiate 4Molecular spectroscopy tracks living mammalian cells in real time as they differentiate 5Vitamin D supplements may protect against viral infections during the winter 2Researchers develop rapid test strips for bacterial contamination in swimming water 2
... Rat adult normal paraffin tissue array ... or proteins of interest in extensive ... Rat brain, heart, kidney, liver, ... are arrayed on positively charged glass ...
Rat Normal Multiple Tissue Array 1 slide...
... DeStreak Reagent, 1 ml. ... 2-D gels by preventing streaking.Eliminates ... oxidation of proteins.Stabilizes proteins throughout ... simplified, well-resolved protein patterns.Ideal for ...
Request Info...
Biology Products: